[1]
P. Prasathinphimai and L. Wongluechai, “Predictors and Outcomes of Erythrocytosis After Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes Mellitus”, J Nephrol Soc Thail, vol. 30, no. 2, pp. 157–167, May 2024.